Literature DB >> 15002740

The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.

Meng-Yang Zhu1, Patrick B Kyle, Arthur S Hume, Gregory A Ordway.   

Abstract

The present study examined the potential membrane retention of desipramine (DMI) following exposures of 293-hNET cells to DMI, and its effect on [3H]NE uptake. Incubation of cells with 500 nM DMI for 1 h or 1 day persistently inhibited the uptake of [3H]NE up to 7 days, despite daily repeated washing of cells with drug-free medium. Uptake inhibition was paralleled by persistent retention of DMI associated with cells, as determined by HPLC and by radiotracer experiments using [3H]DMI. [3H]DMI trapped in membranes was displaceable by the structurally unrelated NET inhibitor, nisoxetine, in a concentration-dependent manner, implying interaction of retained [3H]DMI with the NET. A similar cellular retention was observed following incubation of cells with nisoxetine. The results demonstrate that DMI and nisoxetine are persistently retained in cell membranes, at least partly in association with the NET. The retention and slow diffusion of DMI and nisoxetine from membranes may contribute to their pharmacological and modulatory action on NET.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002740     DOI: 10.1023/b:nere.0000013747.04964.46

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids.

Authors:  J K Seydel; O Wassermann
Journal:  Biochem Pharmacol       Date:  1976-11-01       Impact factor: 5.858

2.  Evidence for lysosomotropic action of desipramine in cultured human fibroblasts.

Authors:  U E Honegger; A A Roscher; U N Wiesmann
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

3.  Inhibition of phospholipid degradation and changes of the phospholipid-pattern by desipramine in cultured human fibroblasts.

Authors:  R Fauster; U Honegger; U Wiesmann
Journal:  Biochem Pharmacol       Date:  1983-06-01       Impact factor: 5.858

4.  Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter.

Authors:  T Pacholczyk; R D Blakely; S G Amara
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

5.  Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.

Authors:  H E Melikian; S Ramamoorthy; C G Tate; R D Blakely
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

6.  Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors.

Authors:  M Y Zhu; G A Ordway
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

7.  Regulation of the human norepinephrine transporter by cocaine and amphetamine.

Authors:  M Y Zhu; S Shamburger; J Li; G A Ordway
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

8.  Effects of repeated administration of desipramine or electroconvulsive shock on norepinephrine uptake sites measured by [3H]nisoxetine autoradiography.

Authors:  M E Bauer; S M Tejani-Butt
Journal:  Brain Res       Date:  1992-06-12       Impact factor: 3.252

9.  Subcellular distribution of the antidepressant drug desipramine in cultured human fibroblasts after chronic administration. Drug-effect on the subcellular distribution of accumulated phospholipids.

Authors:  P Stoffel; T Burkart; U E Honegger; U N Wiesmann
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

10.  Brain distribution and kinetics of desipramine in the rat.

Authors:  P D Hrdina; T C Dubas
Journal:  Can J Physiol Pharmacol       Date:  1981-02       Impact factor: 2.273

View more
  3 in total

1.  Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.

Authors:  Juan Zhen; Solav Ali; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurosci Methods       Date:  2011-09-12       Impact factor: 2.390

2.  N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-21       Impact factor: 3.000

3.  Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.

Authors:  Zaorui Zhao; Alicia M Baros; Han-Ting Zhang; M Danet S Lapiz; Corina O Bondi; David A Morilak; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.